Analysts might anticipate a good upside ahead for CSL shares, but I think this ASX biotech stock is a much better buy.

This S&P/ASX 200 Index (ASX: XJO) stock has gained 63% in 2025 and 813% in five years. Here’s why it’s tipped for more ...

The ASX Ltd (ASX: ASX) share price fell after ASIC ordered a $150m capital charge, resulting in lower return and dividend ...

DroneShield Ltd (ASX: DRO) shares are having a very good session on Tuesday after a big announcement. Here's what is ...

It's been a year of success for the African-focused gold mining company. Its shares have climbed 8.1% higher over the past ...

Following the regulatory setbacks, brokers downgraded Telix Pharmaceuticals' stock due to increased risk and pushed-out ...

Investors have sent this S&P/ASX 200 Index (ASX: XJO) gold stock soaring in 2025. Here’s why it could keep racing higher in ...

Life360 falls almost 6% as tech stocks face broader sell-offs amidst concerns of an AI bubble, impacting the S&P/ASX All ...

Looking to snap up some quality, dividend paying ASX REITs forecast to surge 14% to 73% in 2026? Then you’ll want to read ...

While Westpac has been a solid investment, its current high valuation might make exchange traded funds a smarter choice for ...

Looking for ASX blue chip shares with big dividend yields? Here are three, including Rio Tinto, that still offer 4% or higher ...

Bell Potter believes this ASX mining stock could rocket due to improved sentiment in the lithium space and the company's ...